A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients
A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients
Active, not recruiting · NCT06879717 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients | Advanced Non Squamous NSCLC; Non-Squamous Non-Small Cell Lung Cancer (NSCLC) | Active, not recruiting | Phase 1 / Phase 2 | 2026-01-16 | NCT06879717 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| iOnctura | 6 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Antwerp University Hospital | Antwerp | Belgium | 2 |
| AZ Delta vzw | Roeselare | Belgium | 14 |
| Hospital Universitari Son Espases | Palma | Spain | 16 |
| Hospital Universitario y Politécnico La Fe | Valencia | Spain | 26 |
| Humanitas University, Department of Medical Oncology | Rozzano | Italy | 1 |
| Institut Català d'Oncologia Hospitalet | Barcelona | Spain | 1 |
| Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" | Meldola | Italy | 1 |